Physician profile
Kenneth Q Phi
NPI 1770979940
$5,849.07
in general payments reported to CMS, 2019-2025
15 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $485 · 2021: $948 · 2022: $1,146 · 2023: $962 · 2024: $458 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,440.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,433.37 | 2019-2025 | Precision 1, Total30, Precision7 |
| Johnson & Johnson Vision Care, INC. | $1,021.31 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $837.28 | 2022-2025 | Infuse |
| Coopervision INC. | $821.33 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Notal Vision, INC. | $538.43 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $288.57 | 2019-2021 | |
| Biotissue Holdings INC. | $212.70 | 2019-2020 | |
| Glaukos Corporation | $168.58 | 2020-2022 | |
| Abbvie INC. | $162.67 | 2023-2025 | |
| Horizon Therapeutics Plc | $123.88 | 2023 | Tepezza |
| Rxsight INC | $100.09 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Mallinckrodt Hospital Products INC. | $58.99 | 2024-2025 | Acthar |
| Shire North American Group INC | $48.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.34 | 2022 | |
| Abb Con-Cise Optical Group LLC | $6.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Phi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.